News
A twice-yearly injection could help Australia eliminate HIV, but experts are sounding the alarm over its prohibitive cost.
By publishing more than 200 complete response letters, the FDA is offering new visibility into the issues that most often ...
4d
Bucyrus Telegraph-Forum on MSNAvita’s new drug program gives unused meds to patients in needAvita has a new Drug Repository Program that will distribute donated unexpired prescription medications to qualifying ...
Minister of Health and Wellness Dr. Michael Darville said yesterday that a bill that would integrate the prescription drug ...
- NDA assigned a Target Action Date of February 25, 2026 - ...
Abrupt online-only compliance filing shift risks disrupting nearly 45% of India’s pharma exports to Rest of the Word markets, ...
"EQUIP-A-Pharma is about point-of-need manufacturing—hospitals, military bases, disaster zones—ensuring rapid drug ...
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.
SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced today that the China National Medical ...
The FDA has released an “initial batch“ of more than 200 complete response letters (CRLs) in efforts to boost transparency. | ...
Damascus House, a faith-based rehabilitation program, planned to expand into Georgetown Baptist Church. Now it's looking for ...
FDA assigns PDUFA target action date of January 31, 2026 WARREN, N.J., June 16, 2025 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results